Resources

Awareness of Nucleic Acid-Based Therapies

Home | Resources

In this Syndicated Report we had two goals:

  • Provide a baseline understanding of current knowledge among physicians regarding the types of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.
  • Serve as a vehicle for future surveys to assess how knowledge and perceptions change over time.

Methodology: 12-Minute MicroSurvey
Crowds: PCPs, Oncologists, & Pediatricians
Sample Size: n=250
Fielding Period: September 8-10, 2019

This report explores physician awareness of the following RNA- or DNA-based therapeutic methods:

  • RNAi (RNA interference)
  • siRNA (short interfering RNAs)
  • ASO (antisense oligonucleotides)
  • mRNA (messenger ribonucleic acid)
  • AAV (adeno-associated virus)
  • CRISPR (clustered regularly interspaced short palindromic repeats)
  • TALENs (transcription activator-like effector nuclease)

Download the report now!

Please fill out the form below to access this content

Related Resources

2025 State of Healthcare Report: April 

2025 State of Healthcare Report: April 

Timely insights from patients and healthcare providers on the impact of policy changes, cost shifts, and access challenges. From rising out-of-pocket costs to concerns over Medicare and Medicaid, the U.S. healthcare landscape is in flux, and patients and providers are...

read more
IV Fluid Supply Chain Disruptions 

IV Fluid Supply Chain Disruptions 

Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...

read more
Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more